Cell Tradition Media Market Kind, Utility Finish-user, and . By


DUBLIN, March 30, 2022 (Globe Newswire) — “Cell Tradition Media Market by Kind (Serum-free (CHO, BHK, Vero Cell), Stem Cell, Chemically Outlined, Classical, Characterised), Utility (Biopharmaceutical (mAbs) , Vaccines), Diagnostics, Tissue Engineering), Finish Person (Pharma, Biotech) – World Forecast to 2026”. ResearchAndMarkets.com’s Presentation.

The worldwide cell tradition media market is projected to develop from USD 4.9 billion in 2021 to USD 10.3 billion by 2026, at a CAGR of 16.0% between 2021 and 2026.

The expansion of this market is primarily pushed by rising consciousness about the advantages of cell-based vaccines, rising demand for monoclonal antibodies (mAbs), funding for cell-based analysis, development in stem cell analysis, launch of recent cell tradition media Is. by market gamers, and rising consideration to personalised drugs. Alternatively, the excessive value of cell biology analysis is restraining the expansion of this market.

Serum-free media phase is chargeable for the very best development charge within the cell tradition media market, by sort, through the forecast interval

In 2020, the serum-free media phase accounted for the most important share of the market. This may be attributed to some great benefits of serum-free media over different forms of media, together with constant efficiency, development and productiveness, higher management over physiological response, and diminished danger of contamination by serum-borne adventitial brokers in cell tradition. is included.

Thermo Fisher Scientific, Inc. (US), Merck KGA (Germany), Danaher Company (US), Sartorius AG (Germany), Corning Integrated (US), Fujifilm Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Becton, Dickinson & Firm (US), Miltenyi Biotech (Germany), Hymedia Laboratories Pvt. Ltd. (India), STEMCELL Applied sciences Inc. (Canada), Biologos LLC (US), Cell Functions, Inc. (US) are a few of the main gamers working within the cell tradition media market.

Asia Pacific: Quickest Rising Area in Cell Tradition Media Market

The cell tradition media market has been segmented into North America, Europe, Asia Pacific, Latin America (LATAM), and Center East and Africa (MEA). The Asia Pacific market is predicted to register the very best CAGR of 17.5% through the forecast interval. Rising getting older, favorable regulatory pointers, authorities assist for cell culture-based vaccine manufacturing, low manufacturing value, and rising focus of worldwide market gamers on rising Asian economies are the foremost elements contributing to the expansion of cell tradition media market. Asia Pacific.

Main matters coated:

1. Introduction

2 Analysis Methodology

3 Govt Abstract

4 Premium Insights
4.1 Cell Tradition Media Market Overview
4.2 North America: Cell Tradition Media Market, by Kind and Nation (2020)
4.3 Cell Tradition Media Market Share by Utility, 2021 Vs. 2026
4.4 Cell Tradition Media Market by Finish-Person, 2020 (USD Million)
4.5 Cell Tradition Media Market: Geographic Development Alternatives

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Driver
5.2.1.1 Enhance in R&D Spending in Pharmaceutical Firms
5.2.1.2 Rising Cell Tradition Applied sciences for Cell Primarily based Vaccines
5.2.1.3 Rising Demand for Monoclonal Antibodies
5.2.1.4 Development in Stem Cell Analysis
5.2.1.5 Launch of New Cell Tradition Media Merchandise by Market Gamers
5.2.1.6 Rising deal with personalised drugs
5.2.2 Restrictions
5.2.2.1 Costly Cell Biology Analysis Merchandise
5.2.2.2 Moral Considerations Concerning Cell Biology Analysis
5.2.3 Alternatives
5.2.3.1 Progress in 3D Cell Tradition
5.2.3.2 Rising Incidence of Infectious Ailments and Epidemic Outbreaks
5.2.3.3 Rising Markets
5.2.4 Challenges
5.2.4.1 Survival of Youthful Gamers and New Entrants
5.3 Vary/Situation
5.4 Developments/constraints affecting buyer enterprise
5.5 Affect of the COVID-19 Outbreak on the Cell Tradition Media Market
5.6 Pricing Evaluation
5.7 Patent Evaluation
5.8 Worth Chain Evaluation
5.9 Provide Chain Evaluation
5.10 Ecosystem Evaluation of Cell Tradition Media Market
5.11 Porter’s Evaluation of the 5 Forces
5.12 Regulatory Evaluation
5.12.1 US
5.12.2 Europe

6 Cell Tradition Media Market, Kind . By
6.1 Introduction
6.1.1 Serum Free Media
6.1.1.1 Chow Media
6.1.1.1.1 Adoption of Chow Media to Drive Development of this Market Phase in Biopharmaceutical Firms
6.1.1.2 Heck 293 Media
6.1.1.2.1 Advantages of Hek 293 Cell Traces Anticipated to Drive Development of this Market Phase
6.1.1.3 BHK Media
6.1.1.3.1 BHK media has huge utility within the manufacturing of recombinant proteins
6.1.1.4 Vero Cell Media
6.1.1.4.1 Rising position of Vero cells in viral vaccine analysis to gasoline the expansion of this market phase
6.1.1.5 Serum Free Stem Cell Media
6.1.1.1.5.1 Funding for Stem Cell Analysis to Drive Development of this Market Phase
6.1.1.6 Insect Cell Media
6.1.1.6.1 Adoption of Insect Cell Media for Heterogeneous Protein Expression is Driving the Development of this Market Phase
6.1.1.7 Automobile T-Cell Media
6.1.1.7.1 Rising Demand for Adaptive T-Cell Remedy to Drive Development of this Market Phase
6.1.1.8 Different Serum-Free Media
6.1.2 Classical Media and Salts
6.1.2.1 Widespread use of classical media and salts in all forms of cell tradition purposes to gasoline the expansion of this market phase
6.1.3 Stem Cell Tradition Media
6.1.3.1 Enhancing collaboration between universities and pharma-biotech firms for stem cell analysis to speed up the expansion of this market phase
6.1.4 Chemically Outlined (CD) Media
6.1.4.1 Functionality of CD Media to Enhance Reproducibility to Drive the Development of this Market Phase
6.1.5 Specialty Media
6.1.5.1 The flexibility to propagate major cells in specialty media is predicted to drive the expansion of this market phase
6.1.6 Different Cell Tradition Media

7 Cell Tradition Media Market, By Utility
7.1 Introduction
7.2 Biopharmaceutical Manufacturing
7.2.1 Monoclonal Antibody Manufacturing
7.2.1.1 Rising demand for monoclonal antibody manufacturing is fueling the expansion of this market phase
7.2.2 Vaccine Manufacturing
7.2.2.1 Rising authorities assist for vaccine manufacturing to speed up development of this market phase
7.2.3 Different Therapeutic Protein Manufacturing
7.3 Diagnostics
7.3.1 Rising incidence of infectious illnesses to drive development of this market phase
7.4 Drug Screening and Improvement
7.4.1 Adoption of Cell-Primarily based Assays in Drug Discovery Will Drive the Development of this Market Phase
7.5 Tissue Engineering and Regenerative Drugs
7.5.1 Cell and Gene Remedy
7.5.1.1 Rising the adoption of cell and gene remedy to deal with sufferers to gasoline the expansion of this market
7.5.2 Different Tissue Engineering and Regenerative Drugs Functions
7.6 Different Functions

8 Cell Tradition Media Market, by Finish-Person
8.1 Introduction
8.2 Pharmaceutical and Biotechnology Firms
8.2.1 Enhance in analysis expenditure by pharma and biotech firms will drive the expansion of this phase
8.3 Hospitals and Diagnostic Laboratories
8.3.1 Rising Functions of Cell Tradition Media in Illness Diagnostics to Speed up the Development of this Phase
8.4 Analysis and Academic Establishments
8.4.1 Enhance in analysis funding to assist the rising prevalence of most cancers and speed up the expansion of this phase
8.5 Different Finish Customers

9 Cell Tradition Media Market, By Area

10 Aggressive Landscapes
10.1 Overview
10.2 Key Participant Methods/Proper to Win
10.3 Market Share Evaluation
10.4 Income Share Evaluation of High Market Gamers
10.5 Firm Valuation Quadrant
10.5.1 Stars
10.5.2 Rising Leaders
10.5.3 Broad Participant
10.5.4 Members
10.6 Firm Valuation Quadrant: Begin-ups/SMEs
10.6.1 Progressive Firms
10.6.2 Initialization Block
10.6.3 Accountable Firms
10.6.4 Dynamic Firms
10.7 Product Footprint of Firms
10.8 Sectoral Footprint of Firms
10.9 Aggressive Panorama

11 Firm Profile
11.1 Key Gamers
11.1.1 Thermo Fisher Scientific, Inc.
11.1.2 Merck KGa
11.1.3 Danaher Company
11.1.4 Sartorius AG
11.1.5 Corning Integrated
11.1.6 Fujifilm Irvine Scientific, Inc. (Acquired by Fujifilm Holdings Company)
11.1.7 Lonza Group AG
11.1.8 Becton, Dickinson & Firm (BD)
11.1.9 Miltenyi Biotech
11.1.10 Himidia Laboratories Pvt. Ltd.
11.1.11 StemCell Applied sciences Inc.
11.1.12 Biology LLC.
11.2 Different gamers
11.2.1 Cell Functions, Inc.
11.2.2 Caisson Laboratories Inc.
11.2.3 Promocell GmbH
11.2.4 Cell Biologics, Inc.
11.2.5 Invivision
11.2.6 Pan-Biotech GmbH
11.2.7 Peprotech, Inc.
11.2.8 Mobile Expertise Restricted LLC.
11.2.9 Zen-Bio, Inc.
11.2.10 Athena Environmental Sciences, Inc.
11.2.11 Cygen Biosciences
11.2.12 BioWest SaaS
11.2.13 Akron Biotech

12 Appendix

For extra details about this report, go to https://www.researchandmarkets.com/r/a7i98h

  • World Cell Tradition Media Market


        



Supply hyperlink